Acera Surgical -Synthetic Hybrid-Scale Fiber Matrix

Acera`s patented technology enables the engineering of matrices which closely resemble the architecture of native tissue. The hybrid-scale fiber products developed with this technology have been shown to deliver patient healing without the limitations of traditional biologics.

Hybrid-scale fiber matrices are engineered from electrospun fibers ranging in fiber diameter (from a few nanometers to a few microns) to create a fully resorbable healing scaffold. Native cells rapidly infiltrate the scaffold, and then proliferate and differentiate to form new granulation tissue.

Gradual and defined resorption of a hybrid-scale fiber matrix is designed to occur at a similar rate to cellular ingrowth and new tissue formation of the surrounding native tissue. As the scaffold resorbs, the porosity of the matrix gradually increases to support continued tissue integration and neovascularization, while eliciting a minimal inflammatory response.

Synthetic hybrid-scale fiber matrices are easy to handle and apply in the clinical setting. The soft and flexible material easily conforms to the wound site, yet is strong enough to manipulate and suture as needed.

While researchers have studied the potential of electrospun fibers for many years, Acera`s technology platform has enabled their practical application for patient healing.

Hybrid-scale fiber matrices are completely synthetic and do not elicit excessive inflammation, a complaint of traditional treatments. The fully synthetic raw materials used to fabricate our products are also ideal for patients who raise ethical or religious objections to traditional biologics.

With our patented technology, Acera Surgical has engineered a revolution in healing.